Zydus Lifesciences Limited (ZYDUSLIFE) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.018x

Based on the latest financial reports, Zydus Lifesciences Limited (ZYDUSLIFE) has a cash flow conversion efficiency ratio of 0.018x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.68 Billion ≈ $39.84 Million USD) by net assets (Rs209.41 Billion ≈ $2.26 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zydus Lifesciences Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Zydus Lifesciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Zydus Lifesciences Limited carry for a breakdown of total debt and financial obligations.

Zydus Lifesciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zydus Lifesciences Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
OGE Energy Corporation
NYSE:OGE
0.077x
RYOHIN UNSP.ADR/1
F:3RKU
N/A
Getlink SE
PA:GET
0.135x
Shenzhen Transsion Holdings Co Ltd
SHG:688036
0.165x
Waaree Energies Limited
NSE:WAAREEENER
0.088x
Macrotech Developers Limited
NSE:LODHA
0.062x
Viper Energy Ut
NASDAQ:VNOM
0.039x
Revvity Inc.
NYSE:RVTY
0.025x

Annual Cash Flow Conversion Efficiency for Zydus Lifesciences Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Zydus Lifesciences Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see ZYDUSLIFE market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs263.58 Billion
≈ $2.85 Billion
Rs67.77 Billion
≈ $732.87 Million
0.257x +77.78%
2024-03-31 Rs221.02 Billion
≈ $2.39 Billion
Rs31.96 Billion
≈ $345.67 Million
0.145x +5.89%
2023-03-31 Rs196.88 Billion
≈ $2.13 Billion
Rs26.89 Billion
≈ $290.78 Million
0.137x +23.67%
2022-03-31 Rs190.54 Billion
≈ $2.06 Billion
Rs21.04 Billion
≈ $227.55 Million
0.110x -49.93%
2021-03-31 Rs149.30 Billion
≈ $1.61 Billion
Rs32.93 Billion
≈ $356.13 Million
0.221x +3.10%
2020-03-31 Rs117.10 Billion
≈ $1.27 Billion
Rs25.05 Billion
≈ $270.95 Million
0.214x -13.31%
2019-03-31 Rs116.79 Billion
≈ $1.26 Billion
Rs28.82 Billion
≈ $311.71 Million
0.247x +139.88%
2018-03-31 Rs89.36 Billion
≈ $966.34 Million
Rs9.19 Billion
≈ $99.42 Million
0.103x -45.75%
2017-03-31 Rs71.16 Billion
≈ $769.58 Million
Rs13.49 Billion
≈ $145.94 Million
0.190x -47.81%
2016-03-31 Rs54.87 Billion
≈ $593.43 Million
Rs19.94 Billion
≈ $215.62 Million
0.363x +61.65%
2015-03-31 Rs44.20 Billion
≈ $478.06 Million
Rs9.94 Billion
≈ $107.45 Million
0.225x -9.20%
2014-03-31 Rs35.83 Billion
≈ $387.52 Million
Rs8.87 Billion
≈ $95.93 Million
0.248x +28.35%
2013-03-31 Rs30.64 Billion
≈ $331.34 Million
Rs5.91 Billion
≈ $63.90 Million
0.193x +2.37%
2012-03-31 Rs26.64 Billion
≈ $288.10 Million
Rs5.02 Billion
≈ $54.28 Million
0.188x -37.02%
2011-03-31 Rs22.38 Billion
≈ $242.07 Million
Rs6.70 Billion
≈ $72.41 Million
0.299x -21.11%
2010-03-31 Rs16.68 Billion
≈ $180.36 Million
Rs6.32 Billion
≈ $68.39 Million
0.379x +118.22%
2009-03-31 Rs12.58 Billion
≈ $136.05 Million
Rs2.19 Billion
≈ $23.64 Million
0.174x +1.43%
2008-03-31 Rs10.82 Billion
≈ $116.97 Million
Rs1.85 Billion
≈ $20.04 Million
0.171x -40.22%
2007-03-31 Rs8.80 Billion
≈ $95.14 Million
Rs2.52 Billion
≈ $27.26 Million
0.287x +80.46%
2006-03-31 Rs7.00 Billion
≈ $75.66 Million
Rs1.11 Billion
≈ $12.02 Million
0.159x -58.87%
2005-03-31 Rs5.93 Billion
≈ $64.17 Million
Rs2.29 Billion
≈ $24.78 Million
0.386x -11.46%
2004-03-31 Rs5.36 Billion
≈ $58.01 Million
Rs2.34 Billion
≈ $25.30 Million
0.436x --

About Zydus Lifesciences Limited

NSE:ZYDUSLIFE India Drug Manufacturers - Specialty & Generic
Market Cap
$9.71 Billion
Rs897.46 Billion INR
Market Cap Rank
#2281 Global
#91 in India
Share Price
Rs891.90
Change (1 day)
-2.08%
52-Week Range
Rs860.60 - Rs1047.85
All Time High
Rs1302.00
About

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers active pharmaceutical ingredients, finished dosage formulations, generics, specialty, biosimilars, vaccines, novel products, con… Read more